+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transcatheter Devices Market by Product Type, Application, Access Route, End User, Distribution Channel - Global Forecast to 2030- Product Image
Transcatheter Devices Market by Product Type, Application, Access Route, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Transcatheter Devices Market by Product Type, Application, Access Route, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896810
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Transcatheter Devices Market grew from USD 15.97 billion in 2024 to USD 18.25 billion in 2025. It is expected to continue growing at a CAGR of 13.74%, reaching USD 34.60 billion by 2030.

Introduction to the Transcatheter Innovation Era

The field of transcatheter devices has revolutionized cardiovascular care by offering minimally invasive alternatives to traditional open-heart procedures. Over the past decade, innovative catheter-based techniques have enabled clinicians to treat complex valve disorders and structural heart defects with reduced perioperative risk and shorter hospital stays. This shift has not only improved patient outcomes but also propelled transcatheter interventions from niche applications to mainstream standards of care in leading cardiac centers.

As pressure mounts to optimize healthcare efficiency and respond to an aging population, the adoption of transcatheter solutions continues to accelerate. Patients with comorbidities who were once considered inoperable have found new hope through advancements in delivery systems, embolic protection devices, and percutaneous closure technologies. In turn, healthcare providers are embracing multidisciplinary heart teams to evaluate patient suitability, refine procedural protocols, and integrate novel imaging modalities.

Against this backdrop of clinical progress and rising demand, stakeholders across the value chain-from device manufacturers to regulatory bodies-are navigating a dynamic market landscape. This executive summary distills the latest transformative shifts, policy impacts, segmentation dynamics, and strategic recommendations, offering decision-makers a consolidated view of the transcatheter devices arena in 2025.

Transformative Shifts Reshaping the Transcatheter Landscape

In recent years, the transcatheter devices market has seen a convergence of technologies that reshape procedural workflows and patient management. Advanced catheter materials with enhanced flexibility and biocompatibility have enabled more precise navigation through the vascular system, reducing trauma and improving procedural success rates. Simultaneously, digital integration of intraprocedural imaging and three-dimensional modeling has empowered operators to plan and execute interventions with unprecedented accuracy.

Beyond technological refinements, evolving reimbursement frameworks and value-based care models are incentivizing shorter hospital stays and streamlined care pathways. The proliferation of outpatient surgical centers equipped for transcatheter valve replacements and closure procedures illustrates a shift toward decentralized service delivery. Moreover, as remote monitoring platforms become more sophisticated, clinicians can track post-procedure recovery in real time, driving continuous quality improvement and patient engagement.

Regulatory authorities have responded by expediting pathways for breakthrough devices, fostering a climate of rapid innovation. Collaboration between manufacturers, research institutions, and clinical centers is leading to hybrid operating suites and simulation-based training programs that accelerate operator proficiency. These transformative forces are coalescing to establish transcatheter interventions as a cornerstone of modern cardiac care.

Assessing the Impact of 2025 Tariffs on the US Market

The United States’ economic policy in 2025 introduced tariffs targeting select components critical to transcatheter device manufacture, including specialty alloys and polymer compounds. As a result, manufacturers have faced upward pressure on production costs, prompting strategic reviews of supply chain footprints. Many device makers are evaluating nearshore sourcing partnerships to mitigate freight expenses and lead-time uncertainties, while others are exploring vertical integration to secure access to raw materials.

These tariff measures have had a pronounced impact on pricing dynamics, with cost increases partially transferred to healthcare providers and, ultimately, payers. To preserve adoption momentum, some companies have negotiated volume-based rebates and risk-sharing agreements tied to clinical outcomes. At the same time, the reconfiguration of procurement strategies is driving investments in alternative materials science, as firms seek to reduce dependency on tariff-exposed inputs.

Despite the immediate cost pressures, the long-term effect of these tariffs may accelerate regional manufacturing capabilities within North America. Government incentives for domestic production are fostering the development of local supply clusters, enhancing resilience against future trade fluctuations. For stakeholders, understanding the multifaceted implications of these tariff policies is essential to navigating cost management and maintaining access to critical transcatheter technologies.

Unveiling Segmentation Dynamics Across Product and Application Landscapes

A granular view of product segmentation reveals a complex ecosystem where Delivery Systems lead in procedural enablement. Within this segment, catheter-based platforms have gained traction due to their flexibility and patient comfort, while sheath-based alternatives offer streamlined handling for high-volume centers. Embolic Protection Devices complement these delivery systems, with filter-based protection and occlusion balloon solutions safeguarding against procedural embolization, and proximal protection devices addressing unique anatomical challenges.

Heart Valves constitute a foundational segment of transcatheter offerings. The aortic valve continues to command the largest procedural volume, yet mitral and tricuspid valve interventions are emerging as next-generation growth drivers. Technological advances in valve design, including adaptive frame geometries and polymeric leaflets, are widening clinical applicability across varied patient profiles. The intracardiac occluder market further diversifies procedural options, as atrial septal defect occluders evolve alongside left atrial appendage and patent foramen ovale occluders.

Access Routes are pivotal to procedural success, with transfemoral approaches dominating due to reduced invasiveness, while transapical and transaortic paths serve anatomies unsuitable for peripheral access. Transjugular and transseptal techniques continue to expand the reach of interventions to challenging cases. End User profiles range from hospital cardiac catheterization labs to cardiac specialty clinics and ambulatory surgical centers, reflecting the decentralization trend. Distribution strategies balance direct sales relationships with channel partnerships to optimize market penetration across diverse geographies.

Regional Variations Driving Market Growth and Adoption Patterns

The Americas remain at the forefront of transcatheter device adoption, driven by robust clinical evidence generation and reimbursement support for structural heart procedures. Leading medical centers in the United States and Canada are early adopters of next-generation valve systems, and increasing procedure volumes support a thriving ecosystem of training programs and research initiatives. In Latin America, rising investments in healthcare infrastructure and expanding cardiology networks are gradually increasing access to minimally invasive interventions.

In Europe, Middle East, and Africa, heterogeneous regulatory frameworks create both challenges and opportunities. While Western European nations benefit from centralized approval processes and comprehensive reimbursement policies, many emerging markets within this region are adopting frameworks that incentivize foreign direct investment and local manufacturing. Collaborative initiatives between governments and industry are streamlining clinical trial approvals, bolstering device registries, and promoting knowledge exchange across borders.

The Asia-Pacific region stands out for its demographic drivers and a rapidly expanding patient pool. China, India, and Southeast Asian countries are scaling up transcatheter programs by investing in specialized heart centers and developing indigenous manufacturing capabilities. Regulatory harmonization efforts across regional blocs are reducing entry barriers, and an expanding middle-class demographic with high cardiovascular risk profiles is accelerating demand for minimally invasive treatment options.

Competitive Landscape and Leading Innovators in Transcatheter Devices

Leading device manufacturers continue to jockey for market leadership through product innovation and strategic partnerships. A major player is recognized for its broad transcatheter heart valve portfolio and ongoing development of next-generation bioprosthetic materials. Another key competitor has leveraged strong R&D capabilities to introduce a novel embolic protection device with modular design features that can integrate with multiple delivery platforms. A third prominent company has concentrated efforts on expanding its occluder range, capitalizing on growing demand for left atrial appendage closure in patients with atrial fibrillation.

In addition to established multinationals, agile growth-stage companies are carving out niches by focusing on device components such as steerable introducer systems and advanced imaging guidance solutions. Several of these emerging firms have formed alliances with academic centers to validate their technologies in first-in-human studies. Furthermore, recent mergers and acquisitions have reshaped the competitive landscape, with larger entities absorbing specialized startups to bolster their product pipelines and geographic reach.

Strategic Recommendations for Industry Leadership and Growth

To sustain growth in this dynamic environment, industry leaders should prioritize integrated technology platforms that combine delivery systems with real-time imaging and analytics. Strengthening partnerships with academic and clinical institutions can accelerate the validation of new device iterations and streamline regulatory approvals. In parallel, diversifying supply chains by engaging regional contract manufacturers will mitigate tariff risks and reinforce operational resilience.

Moreover, tailoring market access strategies to regional reimbursement frameworks is essential for broad adoption. Engaging early with payers to demonstrate value through health-economic models and patient-reported outcomes will facilitate favorable coverage decisions. Companies should also consider service-based offerings, such as physician training programs and outcome monitoring services, to differentiate their solutions and foster long-term customer relationships. Finally, expanding into underserved markets through localized clinical education and favorable distribution agreements can unlock new growth corridors.

Rigorous Methodology Underpinning Market Insights

This analysis draws on a combination of primary and secondary research methodologies. Primary insights were obtained through in-depth interviews with key opinion leaders, interventional cardiologists, and hospital procurement specialists. Real-world procedural data and device utilization metrics were sourced from leading clinical registries and health system partners.

Secondary research encompassed a comprehensive review of regulatory filings, patent databases, annual corporate reports, and peer-reviewed literature. Market dynamics were further validated through triangulation with proprietary transaction databases and supply chain analyses. The research approach emphasized data accuracy, relevance, and neutrality, ensuring that findings reflect the most current industry developments while avoiding forecasting bias.

Concluding Perspectives on Opportunities and Challenges

As transcatheter interventions continue to evolve, the convergence of technological innovation, shifting healthcare economics, and evolving regulatory landscapes presents both opportunities and challenges for industry participants. Stakeholders who proactively adapt to policy changes, invest in device differentiation, and cultivate robust clinical evidence will be best positioned to shape the future of minimally invasive cardiovascular care.

By understanding the nuanced segmentation dynamics, regional adoption patterns, and competitive strategies outlined in this summary, decision-makers can chart a clear path toward sustainable growth. The imperative now is to translate these insights into decisive action, leveraging collaboration and strategic foresight to deliver transformative patient outcomes and secure long-term market leadership.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Delivery System
      • Catheter Based Systems
      • Sheath Based Systems
    • Embolic Protection Device
      • Filter Based Protection
      • Occlusion Balloon Device
      • Proximal Protection Device
    • Heart Valve
      • Aortic Valve
      • Mitral Valve
      • Pulmonary Valve
      • Tricuspid Valve
    • Occluder
      • Atrial Septal Defect Occluder
      • Left Atrial Appendage Occluder
      • Patent Foramen Ovale Occluder
    • Vascular Closure Device
      • Extravascular Clips
      • Intravascular Plugs
      • Suture Based Systems
  • Application
    • Aortic Valve Replacement
      • Balloon Expandable
      • Self Expandable
    • Atrial Septal Defect Closure
      • Amplatzer Septal Occluder
      • Helex Occluder
    • Left Atrial Appendage Occlusion
      • Amulet
      • Watchman
    • Mitral Valve Repair
      • Edge To Edge Repair
      • Replacement
    • Patent Foramen Ovale Closure
      • Amplatzer Pfo Occluder
    • Pulmonary Valve Replacement
      • Melody Valve
      • Sapien Valve
    • Tricuspid Valve Repair
      • Triclip
  • Access Route
    • Transaortic
    • Transapical
    • Transfemoral
    • Transjugular
    • Transseptal
  • End User
    • Ambulatory Surgical Centers
    • Cardiac Specialty Clinics
    • Hospitals
  • Distribution Channel
    • Direct Sales
    • Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • Cook Medical LLC
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • Merit Medical Systems, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transcatheter Devices Market, by Product Type
8.1. Introduction
8.2. Delivery System
8.2.1. Catheter Based Systems
8.2.2. Sheath Based Systems
8.3. Embolic Protection Device
8.3.1. Filter Based Protection
8.3.2. Occlusion Balloon Device
8.3.3. Proximal Protection Device
8.4. Heart Valve
8.4.1. Aortic Valve
8.4.2. Mitral Valve
8.4.3. Pulmonary Valve
8.4.4. Tricuspid Valve
8.5. Occluder
8.5.1. Atrial Septal Defect Occluder
8.5.2. Left Atrial Appendage Occluder
8.5.3. Patent Foramen Ovale Occluder
8.6. Vascular Closure Device
8.6.1. Extravascular Clips
8.6.2. Intravascular Plugs
8.6.3. Suture Based Systems
9. Transcatheter Devices Market, by Application
9.1. Introduction
9.2. Aortic Valve Replacement
9.2.1. Balloon Expandable
9.2.2. Self Expandable
9.3. Atrial Septal Defect Closure
9.3.1. Amplatzer Septal Occluder
9.3.2. Helex Occluder
9.4. Left Atrial Appendage Occlusion
9.4.1. Amulet
9.4.2. Watchman
9.5. Mitral Valve Repair
9.5.1. Edge To Edge Repair
9.5.2. Replacement
9.6. Patent Foramen Ovale Closure
9.6.1. Amplatzer Pfo Occluder
9.7. Pulmonary Valve Replacement
9.7.1. Melody Valve
9.7.2. Sapien Valve
9.8. Tricuspid Valve Repair
9.8.1. Triclip
10. Transcatheter Devices Market, by Access Route
10.1. Introduction
10.2. Transaortic
10.3. Transapical
10.4. Transfemoral
10.5. Transjugular
10.6. Transseptal
11. Transcatheter Devices Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cardiac Specialty Clinics
11.4. Hospitals
12. Transcatheter Devices Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
13. Americas Transcatheter Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Transcatheter Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Transcatheter Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Edwards Lifesciences Corporation
16.3.2. Medtronic plc
16.3.3. Abbott Laboratories
16.3.4. Boston Scientific Corporation
16.3.5. W. L. Gore & Associates, Inc.
16.3.6. Terumo Corporation
16.3.7. Cook Medical LLC
16.3.8. MicroPort Scientific Corporation
16.3.9. Biotronik SE & Co. KG
16.3.10. Merit Medical Systems, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TRANSCATHETER DEVICES MARKET MULTI-CURRENCY
FIGURE 2. TRANSCATHETER DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. TRANSCATHETER DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. TRANSCATHETER DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. TRANSCATHETER DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TRANSCATHETER DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY CATHETER BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY SHEATH BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY FILTER BASED PROTECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUSION BALLOON DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PROXIMAL PROTECTION DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY EXTRAVASCULAR CLIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY INTRAVASCULAR PLUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY SUTURE BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY SELF EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AMPLATZER SEPTAL OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY HELEX OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AMULET, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY WATCHMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY EDGE TO EDGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AMPLATZER PFO OCCLUDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY MELODY VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY SAPIEN VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRICLIP, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRANSAORTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRANSAPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRANSJUGULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY TRANSSEPTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES TRANSCATHETER DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 108. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 110. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 111. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 112. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 113. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 114. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 116. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 117. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 118. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 119. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 120. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 121. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 122. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 123. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. CANADA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 127. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 129. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 130. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 134. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 135. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 136. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 137. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 138. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 139. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. MEXICO TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA TRANSCATHETER DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 213. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 214. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 215. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 216. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 219. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 220. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 221. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 222. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 223. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 224. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 225. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 226. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. GERMANY TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 228. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 230. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 233. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 234. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 236. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 237. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 238. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 239. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 240. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 241. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 242. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 243. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. FRANCE TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 264. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 265. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 266. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 267. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 268. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 270. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 271. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 272. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 273. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 274. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 275. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 276. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 277. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. ITALY TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 281. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 282. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 283. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 285. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 287. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 288. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 292. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 293. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 295. SPAIN TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY DELIVERY SYSTEM, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICE, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY HEART VALVE, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY OCCLUDER, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY VASCULAR CLOSURE DEVICE, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY AORTIC VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY ATRIAL SEPTAL DEFECT CLOSURE, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY LEFT ATRIAL APPENDAGE OCCLUSION, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY PATENT FORAMEN OVALE CLOSURE, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY PULMONARY VALVE REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY ACCESS ROUTE, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES TRANSCATHETER DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA TRANSCATHETER DEVICES MARKET

Companies Mentioned

The companies profiled in this Transcatheter Devices market report include:
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • Cook Medical LLC
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • Merit Medical Systems, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 18.25 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.6 Billion
Compound Annual Growth Rate13.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Transcatheter Devices Market Size, Share & Trends Analysis Report By Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Replacement Devices), By Application (Cardiovascular, Oncology), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Transcatheter Devices Market Size, Share & Trends Analysis Report By Product (Transcatheter Embolization & Occlusion Devices, Transcatheter Replacement Devices), By Application (Cardiovascular, Oncology), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Transcatheter Devices Market by Product, by Application, by End-User, and By Region - Product Image

Transcatheter Devices Market by Product, by Application, by End-User, and By Region

  • Report
  • 200 Pages
  • Global
From
Transcatheter Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Transcatheter Devices Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Kern's Cardiac Catheterization Handbook. Edition No. 7 - Product Image

Kern's Cardiac Catheterization Handbook. Edition No. 7

  • Book
Structural Heart Devices Market by Product Type, Procedure Type, Material Type, End User, Application - Global Forecast to 2030 - Product Image

Structural Heart Devices Market by Product Type, Procedure Type, Material Type, End User, Application - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From

About the Transcatheter Device Market

The Transcatheter Device market is a subset of the Cardiovascular Devices market, which includes a range of medical devices used to diagnose and treat cardiovascular diseases. Transcatheter Devices are minimally invasive devices used to treat structural heart diseases, such as valvular heart disease, congenital heart disease, and coronary artery disease. These devices are inserted through a catheter, which is inserted through a small incision in the skin, and are used to replace, repair, or reconstruct damaged heart valves, vessels, and other structures. Transcatheter Devices are becoming increasingly popular due to their minimally invasive nature, which reduces the risk of complications and recovery time. Some of the major companies in the Transcatheter Device market include Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Terumo. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.